All News

Giant-Cell_Vasculitis.jpg

IL-6 Blocker Succeeds in Real-World Vasculitis

d RheumNow

Tocilizumab (Actemra) was effective for refractory giant cell arteritis (GCA) in real-world practice, although serious infections occurred relatively frequently, Spanish investigators reported.

Read Article
doctors.%20fellows.jpg

Assessing the Performance of Aging Physicians

d Jack Cush, MD

A JAMA Viewpoint article examines the performance of aging surgeons and notes that the effects of aging affects physicians variably and that physician competency should be based on functional age (and abilities) rather than chronologic age. This argues against a mandatory retirement age for surgeons.

Read Article
renal.stone_.LBP_.jpg

Early Predictive Factors for Scleroderma Renal Crisis

d Jack Cush, MD

It has been historically said that risk factors for scleroderma renal crisis (SRC) includes include cold exposure, steroid use, dehydration, rapid progression of skin disease, tendon friction rubs, anti-RNA polymerase III antibodies and pregnancy.  A new study examines risk factor for S

Read Article
diet.better.jpg

Diet and Weight Loss Improves Psoriatic Arthritis

d Jack Cush, MD

Short-term intervention with the very low energy diet (VLED) in psoriatic arthritis (PsA) with obesity (body mass index BMI ≥ 33 kg/m2) showed that weight loss was associated with significant positive benefits on weight and disease activity in joints, entheses and skin. 

Read Article
gout.podagra_0.jpg

Only One-Third of Gout Patients Receive Urate-Lowering Drugs

d Jack Cush, MD

The most recent analysis of National Health and Nutrition Examination Survey [NHANES] 2007-2016) data shows the prevalence of gout to be 9.3 million in the USA.

Read Article
WIR.large_.jpg (keep)

RheumNow Podcast – Gout Spot Light (1.11.19)

d Jack Cush, MD

Dr. Jack Cush discusses the highlights from the past week on RheumNow.com:

Read Article
handOA.JPG

Heberden’s Nodes Predict Knee OA Progression

d Jack Cush, MD

Hand and knee osteoarthritis are considered to be clinically and pathogenically different and distinct, but a new study suggests that Heberden's nodes (HNs) can predict MRI‐based knee osteoarthritis (OA) progression.

Read Article
As always for travelers with fever and joint pain consider endemic viral and other infections, travel risk exposure including STDs and of course merely coincident diseases ( i.e. anchor heuristic) to make the right dx @medicalaxioms @RheumNow @CCalabreseDO https://t.co/ToMZkMI1vB

Links:

Leonard Calabrese LCalabreseDO ( View Tweet)

RA risk increased up to fivefold among patients with high CCP levels https://t.co/6VCMEsqx1p

Links:

Jeff Sparks jeffsparks ( View Tweet)

National registry of lupus nephritis pts w/ ESRD (n=20,974) between 1995-2014 showed that mortality declined from 11.1 to 6.7/100PY; Mortality declined for whites (HR 0.68), blacks (0.67) and Hispanics (0.51) and declined for CVD and infx by 44% & 63% https://t.co/0zDQmLymes

Links:

Dr. John Cush RheumNow ( View Tweet)

Combined study of Danbio (Denmark) and ARTIS (Sweden) RA registries showed that in 8987 treatment courses of abatacept, rituximab or tocilizumab there was no difference in Serious infection rates - ranging from 4.7-8.1 SIE/100 Pt Yrs. https://t.co/JpYDeSPdpy

Links:

Dr. John Cush RheumNow ( View Tweet)

CDC report 5 Jan 2019: 7 million cases of influenza w/ an estimated 69,000 to 84,000 hospitalized for flu-related illness. H1N1 is the most common strain. Flu activity is widespread in 30 states https://t.co/kLsZjKDJen

Links:

Dr. John Cush RheumNow ( View Tweet)

Rheumatology Year in Review : New Drugs, irAEs, Enbrel in court, Opioids, new JAKs, Hot PsA Trial, new Lupus drugs, Medical Marijuana, Expen$ive Rheum drugs, Senolytics. https://t.co/9VpM4yRGfY

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Video on RheumNow - an HLA-B27+ patient with Iritis, Enthesitis, Diarrhea. https://t.co/LusZttdAyw

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Video from RheumNow - The RA patients with Thrombocytopenia https://t.co/GHn6b6Z3kb

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast is up - discussing Gout FDA hearing, Gout Prevalence, ULT use, obesity, BMS-Celgene merger and more. Watch here https://t.co/J5xdqGYWAu Listen on iTunes or here> https://t.co/qHAO4E9cfX

Links:

Dr. John Cush RheumNow ( View Tweet)

FDA AAC + DSRM advisory committee votes 19 yes, 2 no and 1 abstain on continued use of Uloric/febuxostat after reviewing CV risk in the CARES study. Await FDA decision, but Look for label changes.

Dr. John Cush RheumNow ( View Tweet)

QD Video - lessons from the Clinic - How to evaluate the Takayasu's arteritis patient. https://t.co/tZcOOKlcVU

Links:

Dr. John Cush RheumNow ( View Tweet)

“The road to hell is paved with biologic plausibility”. - Dr. Steve Nissan

Dr. John Cush RheumNow ( View Tweet)

Today - anuary 11, 2019: Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting to discuss Safety of Febuxostat v Allopurinol. No webcast. Here are briefing documents https://t.co/DXo3EX8u9y

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×